About

Ariel is an innovative precision medicine company, transforming genetic and clinical data into new insights for the diagnosis and advanced therapeutic alignment and development for complex health conditions. The company has developed the AI-fueled ADVANCE® Platform to identify early symptoms of disease and uncover the causes in each patient and use those insights to develop/align targeted therapeutics. Initially targeting pancreatitis, ADVANCE® will be able to accelerate the early diagnosis and targeted management of other chronic health conditions. Ariel’s clinical decision support tools integrate genetic and clinical data, systems biology, automation and artificial intelligence to determine the biological dysfunction driving a patient’s condition and link to evidence-based medicine and treatments tailored for each patient.